Monoclonal antibodies

The first paper describing this now world-leading class of therapeutics was published in August 1985. Since then, the UK Medical Research Council has received more than £580M in royalties

Sanofi-aventis has opened its BIOLAUNCH project in France, where it plans to invest €200 million to develop biotech expertise.